Abacavir and Tipranavir: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jun 30, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Tipranavir
Abacavir
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed two HIV medicines, tipranavir (Aptivus, taken with ritonavir) and abacavir (Ziagen). When these are taken together, the amount of abacavir in your blood can drop, by roughly 40 to 50 percent in studies. In plain terms, your body may hold onto less abacavir than usual.
The good news is that doctors aren't sure this drop actually weakens how well abacavir controls HIV, and it's something your care team can watch. Please keep taking both exactly as prescribed. Your provider can keep an eye on your HIV lab results (like viral load) to make sure your treatment is still working well.
Effect: Coadministration of tipranavir/ritonavir with abacavir decreases abacavir exposure (Cmax down ~50%, AUC down ~40%).
Direction: Reduced abacavir levels, raising a theoretical concern for reduced antiretroviral efficacy. Onset is delayed; evidence is established from HIV-positive PK studies, though the mechanism is unknown.
- Clinical relevance: Not established; no dosage adjustment recommendations currently available.
- Management: If used together, monitor for continued abacavir efficacy (virologic response, HIV RNA viral load, CD4 trends).
Neither agent's activity here depends on metabolic activation affecting this direction; the net effect is lower abacavir concentrations.
What happens
Decreased abacavir levels
Interaction Deep Dive
Pharmacokinetic investigations in patients who were HIV-positive examined abacavir 300 milligrams (mg) given twice daily together with tipranavir plus ritonavir, administered as tipranavir/ritonavir twice-daily regimens of 250/200 mg (n=28), 750/100 mg (n=14), and 1250/100 mg (n=11). Under these conditions, the maximum serum concentration (Cmax) of abacavir fell by roughly 50%, while its area under the concentration-time curve (AUC) declined by roughly 40%. It remains undetermined whether this interaction carries clinical significance, and no recommendations for adjusting the dose exist at this time. When abacavir is used concurrently with tipranavir and ritonavir, monitoring of patients for abacavir efficacy is advised1.
Why it happens (mechanism)
Unknown
How to manage this interaction
Here is how a care team typically handles this combination:
- Keep taking both medicines as prescribed unless your provider tells you otherwise. Do not stop or change doses on your own.
- Because abacavir levels can be lower, your team may monitor you more closely to confirm your HIV treatment is still working, usually with viral load and other routine labs.
- There is no fixed dose change for this combination, so any adjustments would be individualized by your care team.
Ask your pharmacist or prescriber if you have questions about your lab results or notice any new concerns.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Abacavir and Tipranavir together?
Taking tipranavir/ritonavir with abacavir can lower abacavir levels, but the real-world impact isn't proven; keep taking both as prescribed and let your care team monitor that your HIV treatment stays effective. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abacavir and Tipranavir interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Abacavir and Tipranavir interaction managed?
Here is how a care team typically handles this combination: Keep taking both medicines as prescribed unless your provider tells you otherwise. Do not stop or change doses on your own. Because abacavir levels can be lower, your team may monitor you more closely to confirm your HIV treatment is still working, usually with viral load and other routine labs. There is no fixed dose change for this comb… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Questions for your pharmacist
- Does my dose of Abacavir or Tipranavir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Product Information: Aptivus (R) capsules, tipranavir. Boehringer Ingelheim, Ridgefield, CT, USA, 2005. DailyMed
Keep reading about Tipranavir
Keep reading about Abacavir
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist